West Pharmaceutical Services, Inc.
WST
$214.55
$3.961.88%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 467.20M | 492.70M | 499.60M | 524.90M | 568.70M |
| Total Depreciation and Amortization | 159.80M | 155.40M | 150.60M | 146.10M | 141.30M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00 | 2.40M | 45.90M | 50.20M | 54.80M |
| Change in Net Operating Assets | 37.60M | 2.90M | 6.30M | 31.20M | -8.20M |
| Cash from Operations | 664.60M | 653.40M | 702.40M | 752.40M | 756.60M |
| Capital Expenditure | -357.70M | -377.00M | -380.80M | -395.30M | -370.50M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.70M | -1.70M | -1.90M | -1.00M | -6.70M |
| Cash from Investing | -359.40M | -378.70M | -382.70M | -396.30M | -377.20M |
| Total Debt Issued | 164.70M | 164.70M | 164.70M | 35.00M | -- |
| Total Debt Repaid | -191.90M | -192.40M | -193.00M | -60.40M | -2.50M |
| Issuance of Common Stock | 20.30M | 32.70M | 32.70M | 47.10M | 52.50M |
| Repurchase of Common Stock | -430.20M | -566.60M | -689.10M | -664.80M | -652.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -59.60M | -59.10M | -58.60M | -58.10M | -57.60M |
| Other Financing Activities | -1.90M | -1.90M | 100.00K | 100.00K | -- |
| Cash from Financing | -498.60M | -622.60M | -743.20M | -701.10M | -659.60M |
| Foreign Exchange rate Adjustments | -4.20M | -21.40M | 15.80M | -5.10M | -4.30M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -197.60M | -369.30M | -407.70M | -350.10M | -284.50M |